MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Oracle Co. (NYSE:ORCL - Free Report) by 11.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,006 shares of the enterprise software provider's stock after purchasing an additional 1,687 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in Oracle were worth $2,378,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Capital & Planning LLC boosted its stake in Oracle by 0.5% in the fourth quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider's stock worth $2,621,000 after buying an additional 81 shares in the last quarter. Brighton Jones LLC raised its holdings in shares of Oracle by 189.3% during the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock valued at $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in Oracle in the fourth quarter worth $51,084,000. Revolve Wealth Partners LLC raised its holdings in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock worth $903,000 after purchasing an additional 404 shares in the last quarter. Finally, R Squared Ltd bought a new position in shares of Oracle during the fourth quarter valued at $25,000. 42.44% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on ORCL shares. Cantor Fitzgerald reduced their price objective on Oracle from $214.00 to $175.00 and set an "overweight" rating for the company in a report on Tuesday, March 11th. Monness Crespi & Hardt raised Oracle from a "sell" rating to a "neutral" rating in a research note on Monday, March 3rd. Royal Bank of Canada set a $145.00 target price on Oracle and gave the company a "sector perform" rating in a research report on Tuesday, March 11th. Stephens assumed coverage on Oracle in a research report on Wednesday, March 19th. They issued an "equal weight" rating and a $167.00 price objective on the stock. Finally, UBS Group reissued a "market perform" rating on shares of Oracle in a research report on Tuesday, March 11th. Fourteen analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Oracle currently has an average rating of "Moderate Buy" and a consensus price target of $174.42.
View Our Latest Research Report on ORCL
Insider Buying and Selling
In related news, Director Leon E. Panetta sold 5,000 shares of Oracle stock in a transaction dated Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the transaction, the director now owns 58,090 shares in the company, valued at approximately $7,538,339.30. This trade represents a 7.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Naomi O. Seligman sold 2,866 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $149.53, for a total transaction of $428,552.98. Following the sale, the director now owns 31,764 shares of the company's stock, valued at $4,749,670.92. This trade represents a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,366 shares of company stock valued at $4,015,723. Company insiders own 42.20% of the company's stock.
Oracle Stock Performance
Shares of NYSE:ORCL traded up $2.13 during midday trading on Friday, hitting $165.03. The company's stock had a trading volume of 17,537,919 shares, compared to its average volume of 9,540,302. The stock has a market capitalization of $461.58 billion, a price-to-earnings ratio of 40.35, a PEG ratio of 3.46 and a beta of 1.27. The stock's 50 day simple moving average is $144.55 and its 200 day simple moving average is $161.26. Oracle Co. has a fifty-two week low of $114.55 and a fifty-two week high of $198.31. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81.
Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. During the same period in the previous year, the firm posted $1.41 earnings per share. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, research analysts anticipate that Oracle Co. will post 5 earnings per share for the current year.
Oracle Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were given a $0.50 dividend. The ex-dividend date was Thursday, April 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.21%. This is a boost from Oracle's previous quarterly dividend of $0.40. Oracle's dividend payout ratio is currently 46.95%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report